Medicare Enrolled

Jessica Portu, A.R.N.P

Nurse Practitioner - Adult Health · Boca Raton, FL
701 NW 13TH ST, Boca Raton, FL 33486
5619556400
Registered in NPPES since 2005
NPI: 1588651673 verify on NPPES ↗
High
DATA COVERAGE
Data in 3 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Portu from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Portu? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Portu

Jessica Portu is a nurse practitioner - adult health in Boca Raton, FL, with 20 years of NPI registration.

Between the years covered by Open Payments, Portu received a total of $12,889 from 59 pharmaceutical and/or device companies across 386 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Portu is High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years of NPI registration $12,889 industry payments

Industry Payment Transparency

Open Payments through 2024 ↗
$12,889
Total received (2021-2024)
Avg $3,222/year across 4 years
Top 2% in FL for nurse practitioner - adult health
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
59
Companies
386
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →

Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$4,632
2023
$3,784
2022
$3,175
2021
$1,298

Payments by company (2024)

AstraZeneca Pharmaceuticals LP
$482
PFIZER INC.
$468
Exelixis Inc.
$318
Merck Sharp & Dohme LLC
$276
Astellas Pharma US Inc
$272
Incyte Corporation
$254
ABBVIE INC.
$204
PUMA BIOTECHNOLOGY, INC.
$200
Daiichi Sankyo Inc.
$180
GlaxoSmithKline, LLC.
$169
Takeda Pharmaceuticals U.S.A., Inc.
$168
Lilly USA, LLC
$157
E.R. Squibb & Sons, L.L.C.
$135
Adaptive Biotechnologies Corporation
$133
Gilead Sciences, Inc.
$124
Pharmacosmos Therapeutics Inc.
$121
Celgene Corporation
$113
RECORDATI_RARE_DISEASES_INC.
$101
Novartis Pharmaceuticals Corporation
$99
EMD Serono, Inc.
$79
Alexion Pharmaceuticals, Inc.
$69
Genentech USA, Inc.
$56
Eisai Inc.
$49
Mirati Therapeutics, Inc.
$46
Regeneron Healthcare Solutions, Inc.
$43
BeiGene USA, Inc.
$38
TerSera Therapeutics LLC
$30
GENZYME CORPORATION
$28
SERVIER PHARMACEUTICALS LLC
$25
Fennec Pharmaceuticals, Inc.
$24
Karyopharm Therapeutics Inc.
$23
Kite Pharma, Inc.
$22
TAIHO ONCOLOGY, INC.
$21
Blue Earth Diagnostics Limited
$20
ADC Therapeutics America, Inc.
$20
Alnylam Pharmaceuticals Inc.
$19
Deciphera Pharmaceuticals Inc.
$17
Ipsen Biopharmaceuticals, Inc
$16
Janssen Biotech, Inc.
$14
Top 3 companies account for 27.4% of 2024 payments
All-time payments by company (2021-2024) ›
AstraZeneca Pharmaceuticals LP
$1,330
Astellas Pharma US Inc
$777
PFIZER INC.
$729
E.R. Squibb & Sons, L.L.C.
$617
Exelixis Inc.
$597
GENZYME CORPORATION
$556
PUMA BIOTECHNOLOGY, INC.
$502
Daiichi Sankyo Inc.
$454
Merck Sharp & Dohme LLC
$432
ABBVIE INC.
$409
Celgene Corporation
$375
Gilead Sciences, Inc.
$354
EMD Serono, Inc.
$336
Incyte Corporation
$324
GlaxoSmithKline, LLC.
$307
Lilly USA, LLC
$305
Novartis Pharmaceuticals Corporation
$305
Pharmacyclics LLC, an AbbVie Company
$274
Genentech USA, Inc.
$257
Bayer HealthCare Pharmaceuticals Inc.
$251
Seagen Inc.
$246
Takeda Pharmaceuticals U.S.A., Inc.
$225
Pharmacyclics LLC, An AbbVie Company
$219
Puma Biotechnology, Inc.
$207
Adaptive Biotechnologies Corporation
$191
SOBI, INC
$166
Eisai Inc.
$162
Pharmacosmos Therapeutics Inc.
$146
Kite Pharma, Inc.
$146
Mirati Therapeutics, Inc.
$143
EISAI INC.
$137
Regeneron Healthcare Solutions, Inc.
$135
Foundation Medicine, Inc.
$132
RECORDATI_RARE_DISEASES_INC.
$101
JAZZ PHARMACEUTICALS INC.
$100
Myovant Sciences Inc.
$97
Janssen Biotech, Inc.
$90
BeiGene USA, Inc.
$74
Alexion Pharmaceuticals, Inc.
$69
Deciphera Pharmaceuticals Inc.
$62
TAIHO ONCOLOGY, INC.
$54
TerSera Therapeutics LLC
$53
ADC Therapeutics America, Inc.
$52
Alnylam Pharmaceuticals Inc.
$40
Amgen Inc.
$39
Ipsen Biopharmaceuticals, Inc
$37
ACCORD HEALTHCARE, INC.
$33
Amneal Pharmaceuticals LLC
$28
SERVIER PHARMACEUTICALS LLC
$25
Fennec Pharmaceuticals, Inc.
$24
Karyopharm Therapeutics Inc.
$23
G1 Therapeutics, Inc.
$21
Merck Sharp & Dohme Corporation
$20
Blue Earth Diagnostics Limited
$20
MorphoSys, US Inc.
$18
Dova Pharmaceuticals
$18
Sobi, Inc
$17
Taiho Oncology, Inc.
$15
AbbVie Inc.
$14
Top 3 companies account for 22.0% of all-time payments
Associated products mentioned in payments ›
ALUNBRIG · AVASTIN · BAVENCIO · BLENREP · BOSULIF · BRAFTOVI · BRUKINSA · Bavencio · CABOMETYX · CALQUENCE · CAMCEVI · COSELA · Cabometyx · Columvi · DARZALEX · DOPTELET · Doptelet · ELAHERE · ELIQUIS · ELITEK · ENHERTU · EPKINLY · Enhertu · FRUZAQLA · GIVLAARI · IBRANCE · IDHIFA · IMBRUVICA · IMFINZI · INREBIC · JAKAFI · JEMPERLI · JEVTANA · KEYTRUDA · KISQALI · KRAZATI · LIBTAYO · LONSURF · LUMAKRAS · LYNPARZA · Lenvima · MEKINIST · MONJUVI · MONOFERRIC · NERLYNX · Nubeqa · OJJAARA · ONUREG · OPDIVO · ORGOVYX · OXBRYTA · Onivyde · PADCEV · PIQRAY · PLUVICTO · POSLUMA · Padcev · Pedmark · Pomalyst · QINLOCK · REBLOZYL · RYBREVANT · SARCLISA · SCEMBLIX · SOMATULINE DEPOT · SYLVANT · Stivarga · TABRECTA · TAGRISSO · TECENTRIQ · TEPMETKO · TIVDAK · TUKYSA · Tecentriq · Trodelvy · ULTOMIRIS · VENCLEXTA · VERZENIO · XPOVIO · XTANDI · Xermelo · Xospata · Xtandi · Yescarta · ZEJULA · ZEPZELCA · Zoladex · clonoSEQ
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Looking for a nurse practitioner - adult health in Boca Raton?
Compare adult-health nurse practitioners in the Boca Raton area by procedure volume, costs, and industry payment transparency.
Browse adult-health nurse practitioners nearby

Geographic Context

Adult-health nurse practitioners in nearby ZIP areas
242
County median income
$81,115
Nearest hospital to ZIP centroid (approximate)
BOCA RATON REGIONAL HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPES NPPES snapshot; verify current record
Medicare Enrollment PECOS PECOS snapshot
Practice Data — No data N/A
Industry Payments Open Payments CY 2024
Disciplinary History — Not included N/A

This provider has data in 3 of 4 available federal datasets, with a Data Coverage level of High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Portu is a nurse practitioner - adult health, with 20 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Does Portu receive payments from pharmaceutical companies?
Yes. Portu received a total of $12,889 from 59 companies across 386 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
What does Data Coverage mean?
Data Coverage (currently High for Portu) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
About this page

This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Industry payment disclosure alone establishes neither wrongdoing nor legality. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →